#targetedproteindegradation
A great day at the University of Pavia presenting on new directions in #targetedproteindegradation. Vibrant environment and discussions with colleagues and friends @kajastelab.bsky.social
Thanks @fmagnani.bsky.social for the warm welcome and the opportunity to connect with this scientific community
May 8, 2025 at 4:59 AM
📝 Online now - the Review "E3 ubiquitin ligases in signaling, disease, and therapeutics" from Shaun Olsen et al.

#ubiquitin #E3UbiquitinLigase #UbiquitinProteasomeSystem #TargetedProteinDegradation

Read it here 👉 authors.elsevier.com/sd/article/S...
September 22, 2025 at 2:21 PM
🤝 #MeetOurScientists: Dr. Cristina Mayor-Ruiz, from #IRBBarcelona

🎯🔬 Learn how Dr. Mayor-Ruiz's pioneering work in #TargetedProteinDegradation is unlocking new ways to treat untouchable diseases.

📽️ youtu.be/d8ig0j7fQMM?feature=shared

#Chembio #ProteinDegradation #TPD #IRBScience

🧪
Meet our Scientists - Dr. Cristina Mayor-Ruiz: Advancing Drug Discovery with Protein Degradation
YouTube video by IRB Barcelona
youtu.be
November 28, 2024 at 4:28 PM
🤝 #MeetOurScientists: Dr. @crismayorruiz.bsky.social.

🎯🔬 Learn how Dr. Mayor-Ruiz's pioneering work in #TargetedProteinDegradation is unlocking new ways to treat untouchable diseases.

📽️ https://s.mtrbio.com/higqmhbfzt

#IRBScience #ProteinDegradation #TPD

🧪
Enjoy the videos and music that you love, upload original content and share it all with friends, family and the world on YouTube.
s.mtrbio.com
January 24, 2025 at 10:02 AM
🤝 #IRBBarcelona Group Leader Cristina Mayor-Ruiz has co-authored a Perspective in #MolecularCell proposing the creation of a #EuropeanAlliance to accelerate the development of proximity-induced therapies.

More information here 🔗 www.irbbarcelona.org/en/news/scie...

🧪 #TargetedProteinDegradation
August 21, 2025 at 3:10 PM
New year, new preprint! 🎊

We are excited to share our recent work on #E3 ligase regulation in #metabolism!

www.biorxiv.org/content/10.6...

#ubiquitin #targetedproteindegradation #chemicalbiology

1/6
A CK2-FBXW11 kinase-E3 ubiquitin ligase cascade is a metabolic sensor regulating Tryptophan 2,3-dioxygenase stability
Small molecules toggling the ubiquitin-proteasome system (UPS) are powerful regulators of protein degradation. Yet, mechanistic knowledge of how endogenous ligands gate UPS decisions remains rudimentary. Here, we define control of UPS access to Tryptophan-2,3-dioxygenase (TDO2), which converts the essential amino acid tryptophan (Trp) to N-formylkynurenine. When Trp concentrations are limiting, TDO2 is degraded to avert tryptophanemia. Using CRISPRi screening and biochemistry, we identify a CK2-FBXW11 kinase-E3 ligase cascade that generates and recognizes tandem TDO2 phosphodegrons when not protected by Trp. Trp binding to an exosite safeguards TDO2 from phosphorylation-dependent ubiquitylation. Effects of Trp analogs on CK2-FBXW11-dependent ubiquitylation indicated that the indole, amino, and carboxylate groups are necessary for substrate shielding. Cryo-EM reveals how these moieties order a region proximal to the phosphodegrons; without Trp, this segment is flexible, enabling phosphorylation-coupled ubiquitylation. Overall, our data uncovered an endogenous small molecule allosterically stabilizing its own metabolizing enzyme through protection from a phosphorylation-ubiquitylation cascade. ### Competing Interest Statement B.A.S. is a member of the scientific advisory boards of Proxygen and Lyterian. The other authors declare no competing interests. Max Planck Society, https://ror.org/01hhn8329 European Union, ERC AdvG, UPSmeetMet, 101098161 to BAS Boehringer Ingelheim Fonds, https://ror.org/00dkye506
www.biorxiv.org
January 13, 2026 at 1:49 PM
Continuing on with our TPD-themed day at #AusUb2025, we just had amazing talks on ‘the Frontiers of Innovation in TPD’ from Eric Fischer, Fleur Ferguson, Johannes Yeh, Man Pan, and Mikihiko Naito.
#ubiquitin #TPD #targetedproteindegradation
November 22, 2025 at 2:52 AM
Thank you to all speakers: Hsueh-Chi Sherry Yen, Selina Zhang, Benedikt Kessler, Mengying Zhou, and Fumiaki Ohtake.

#ubiquitin #targetedproteindegradation
November 22, 2025 at 11:58 AM
Online now - the Review "Routes to #MolecularGlueDegrader discovery" from Yanfen Liu, Yong Cang, and colleagues.

#MGD #TargetedProteinDegradation #TPD #PROTAC #HighThroughputScreening

authors.elsevier.com/a/1kN5M3S6Gf...
January 3, 2025 at 4:31 PM
July 14, 2026 at 1:59 PM
Congratulations to @craigmcrews.bsky.social and all others involved at @yale.edu, Arvinas and Pfizer. #InducedProximity should be at the top of many The Nobel Prize lists now.

#TPD #TargetedProteinDegradation #NewModalities #Clinics #DrugDiscovery #DrugDevelopment #Success #ChemSky #ChemBio
May 9, 2026 at 9:35 AM
Registration now open for #EMBOUbiquitin.
meetings.embo.org/event/26-ubi...

Childcare, accessibility, and travel grants available.

#ubiquitin #TargetedProteinDegradation #Proteostasis #UBL
March 5, 2026 at 12:38 PM
Excited to present our work on molecular glue degraders at the SMR Target to Patient conference in the Wellcome Genome Campus next month - looks like a very strong line-up. www.smr.org.uk/Meetings/202... #TargetedProteinDegradation #InducedProximity #MolecularGlues #DrugDiscovery #ChemicalBiology
March 8, 2026 at 5:20 PM
Potential therapeutic target in acute myeloid leukemia (AML): Geng et al. explore the development of molecular glue degraders (MGDs) targeting casein kinase 1 alpha (CK1α), a potential therapeutic target in AML.

Learn more: bit.ly/3OFLfBo

#TargetedProteinDegradation #proteomics #massspectrometry
Preprint: Development of potent and selective CK1α Molecular Glue Degraders - IonOpticks
This molecular glue degraders study by Geng et al. was conducted utilising a 25cm IonOpticks Aurora Ultimate UHPLC column.
bit.ly
December 4, 2024 at 3:49 AM
🧪Announcing the SMART Symposium on Targeted Protein Degradation 2026!
📆November 10-13, 2026
📍Shenzhen, China
🌏Come listen to academic & industry experts from pharma & biotech
🔗Register Now: symposia.smart.org.cn

#SMARTSymposia #SMARTshenzhen ##TargetedProteinDegradation #Pharmacology
May 22, 2026 at 1:49 AM
👀 Strong binding, but no degradation? Join Dr Stefan Mueller on 20 Aug to learn how FCCS on the EI-FLEX Pro HT reveals #ternarycomplex formation and #cooperativity - key insights for #PROTACs and #molecularglues.

Register: us06web.zoom.us/meeting/regi...

#drugdiscovery #targetedproteindegradation
August 10, 2026 at 7:35 AM
A new study in Cell Chemical Biology explored how the mechanism driving oncogene overexpression can determine the effectiveness of protein degraders such as PROTACs.

Link in the comments 👇
#TargetedProteinDegradation #PROTAC #CancerResearch #DrugDiscovery #Oncology
September 23, 2026 at 8:33 PM
Reminder: free webinar tomorrow, Weds, 2 Sept 2026 at 3.00 p.m. (BST): Hold and Kill – RIPTAC Assay Strategy.

Learn how NanoBRET® measures ternary complex formation for this breakthrough "hold-and-kill" approach in clinical trials.

https://ow.ly/FCAG50ZwAel

#TargetedProteinDegradation #RIPTAC
September 1, 2026 at 8:05 AM
VHL ligands engage the VHL E3 ligase, a highly validated recruiter in PROTAC design, offering robust degradation profiles. Their structural diversity supports fine-tuning of ternary complex stability and pharmacological properties.

fluorochem.co.uk/product-cate...

🧪 #TargetedProteinDegradation
October 2, 2025 at 11:13 AM